Insider Trading History of Taylor Andrew Lawrence

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Taylor Andrew Lawrence since 2018. This trader's CIK number is 1723889. At the time of last reporting, Taylor Andrew Lawrence was the Chief Financial Officer of Orchestra Biomed Holdings, Inc.. (stock ticker symbol OBIO). Also see all insider trading activities at Orchestra Biomed Holdings, Inc..

Note that in the past Taylor Andrew Lawrence also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Orchestra Biomed Holdings, Inc. (OBIO) by Taylor Andrew Lawrence

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2025 OBIO 2,000 $5,100 0 $0 0 $0
2024 OBIO 1,000 $4,830 0 $0 0 $0

Yearly summary of insider trading at Motus Gi Holdings, Inc. (MOTS) by Taylor Andrew Lawrence

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2021 MOTS 2,000 $1,022 0 $0 0 $0
2020 MOTS 1,000 $1,080 0 $0 0 $0
2018 MOTS 3,000 $12,700 0 $0 0 $0


Insider trading activities at 2 companies by Taylor Andrew Lawrence:

1. Orchestra Biomed Holdings, Inc. (OBIO)

2. Motus Gi Holdings, Inc. (MOTS)

Table 1. Insider trading of Orchestra Biomed Holdings, Inc. (OBIO) by Taylor Andrew Lawrence

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2025-08-25 OBIO Buy 2,000 2.55 5,100
2024-12-19 OBIO Buy 1,000 4.83 4,830

Table 2. Insider trading of Motus Gi Holdings, Inc. (MOTS) by Taylor Andrew Lawrence

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2021-11-19 MOTS Buy 2,000 .51 1,022
2020-12-09 MOTS Buy 1,000 1.08 1,080
2018-12-24 MOTS Buy 1,000 2.70 2,700
2018-02-16 MOTS Buy 2,000 5.00 10,000

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Taylor Andrew Lawrence (Chief Financial Officer of Orchestra Biomed Holdings, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.